PPA Pharmaceutical Injury Lawyers
PPA Drug Recall Lawyers
What is PPA?
What are some of the side effects of PPA?
Based on the serious side effects of PPA, has the FDA done anything?
What should I do if I've taken PPA?
What is PPA?
Phenylpropanolamine (fen-ill-proe-pa-NOLE-a-meen), commonly known as PPA, is used as a nasal decongestant or as an appetite suppressant. PPA clears nasal congestion by narrowing or constricting the blood vessels.
Back to Top
What are some of the side effects of PPA?
A Yale University study shows that women aged 18 to 49 are 16 times more likely than the average person to suffer a hemorrhagic stroke. PPA constricts blood vessels and raises blood pressure. In certain cases, it can cause blood vessels to rupture, leading to bleeding in the brain and stroke.
Back to Top
Based on the serious side effects of PPA, has the FDA done anything?
In November of 2000, the FDA began taking steps to have PPA removed from all drug products. The FDA has asked firms that market pharmaceutical or drug produces containing PPA to voluntarily discontinue marketing them. The FDA has also alerted consumers to the risks associated with the use of products containing PPA.
Back to Top
What should I do if I've taken PPA?
Discuss any symptoms you have or suspect you have with your doctor. Alternative medications and treatment may be available. We also recommend you contact experienced PPA side effects lawyers such as Kline & Specter. We will review your claim and help you receive the compensation you deserve.
Back to Top
If you or a loved one has suffered a hemmoragic stroke after using a PPA product, you need a law firm with the resources and the experience to bring you justice. Please call or e-mail the pharmaceutical litigation attorneys at Kline & Specter. We'll evaluate your PPA stroke claim for free and we don't get paid unless you do. Our expertise will help you get the compensation you deserve.
Pharmaceutical Injury Lawyers
Call 1-800-597-9585
or
Click here to contact us.
This page was last updated on January 31, 2007.
|
